Category

Earnings Alerts

Labrador Iron Ore Royalty Co (LIF) Earnings: 2Q EPS Misses Estimates Despite Revenue Growth

By | Earnings Alerts
  • Labrador Iron Ore’s Q2 earnings per share (EPS) were C$0.78.
  • EPS missed market estimates of C$0.80 but was higher compared to C$0.65 in the same period last year (y/y).
  • The company reported revenue of C$53.1 million for the quarter.
  • This represents a 3.1% increase year-over-year, exceeding the estimated revenue of C$49.7 million.
  • Rio Tinto’s 2024 guidance for IOC’s saleable production remains between 16.7 million and 19.6 million tonnes.
  • The World Steel Association forecasts global steel demand will grow by 1.7% in 2024.
  • Global steel demand is also expected to grow by 1.2% in 2025.
  • Current analyst recommendations include 1 buy, 5 holds, and 0 sells.

A look at Labrador Iron Ore Royalty Co Smart Scores

FactorScoreMagnitude
Value3
Dividend5
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Labrador Iron Ore Royalty Corp, an unincorporated open-ended trust, holds a promising outlook based on the Smartkarma Smart Scores. With a strong dividend score of 5, investors can expect consistent payouts. The company also received solid scores in momentum, resilience, and value, indicating a stable and potentially growing investment opportunity. While growth scored a 3, the overall assessment presents a positive long-term outlook for Labrador Iron Ore Royalty Co.

Labrador Iron Ore Royalty Co‘s business model focuses on holding an overriding royalty on iron ore products from the Iron Ore Company of Canada. This unique structure positions the company well for steady income generation and shareholder returns. Investors looking for a reliable dividend stock with potential for growth and resilience may find Labrador Iron Ore Royalty Co an attractive option based on its Smartkarma Smart Scores.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Itau Unibanco Holding (ITUB4) Earnings: 2Q Recurring Net Income Hits R$10.07 Billion, Meeting Estimates

By | Earnings Alerts






  • Itau’s recurring net income for Q2 2024 stands at R$10.07 billion.
  • This represents a 15% increase year-over-year (y/y).
  • The net income met the estimated R$10.02 billion.
  • Net interest income is R$27.67 billion, up 6.4% y/y.
  • This slightly missed the estimate of R$27.87 billion.
  • Total loans reached R$1.25 trillion, reflecting an 8.9% growth y/y.
  • Return on average equity is now 22.4%, compared to 20.9% y/y.
  • Total assets have grown by 13% y/y, reaching R$2.93 trillion.
  • Analyst ratings include 14 buys, 3 holds, and no sell recommendations.



A look at Itau Unibanco Holding Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth4
Resilience2
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts at Smartkarma have assessed Itau Unibanco Holding S.A.’s long-term outlook using a comprehensive scoring system. The bank received a solid score of 4 for Growth, indicating a positive trajectory for expanding its operations and market presence. With a Momentum score of 4, Itau Unibanco Holding is showing strong upward momentum in its stock performance. However, the company scored lower in Resilience with a score of 2, suggesting potential vulnerabilities to economic downturns or market shocks.

Overall, Itau Unibanco Holding S.A. seems to be well-positioned for growth and has a favorable momentum in the market. While it presents opportunities for expansion and investment, investors should be mindful of its resilience score and consider potential risks associated with economic uncertainties.

Summary: Itau Unibanco Holding S.A. provides a range of banking services and has received positive scores for Growth and Momentum in its long-term outlook analysis by Smartkarma. However, the company scored lower in Resilience, indicating potential vulnerabilities to market shocks.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Great-West Lifeco (GWO) Earnings Surpass Expectations in 2Q: Base EPS Hits C$1.11

By | Earnings Alerts
  • Base EPS: C$1.11, beating the estimate of C$1.04
  • EPS: C$1.08
  • Base Return on Equity: 17.2%, surpassing the estimate of 16.9%
  • Book Value per Share: C$25.36, exceeding the estimate of C$25.05
  • Assets Under Administration: C$2.93 trillion
  • Total Assets Under Management: C$961.50 billion
  • Market Sentiment: 1 buy, 9 holds, 0 sells
  • Executive Comment: “Our strong momentum is supported by market-leading franchises with focused and disciplined execution of their growth strategies.”

A look at Great-West Lifeco Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Great-West Lifeco Inc., a financial services holding company specializing in life insurance, health insurance, investment, retirement savings, and reinsurance, is positioned with a well-rounded outlook based on the Smartkarma Smart Scores. With strong scores in dividend and momentum, indicating solid returns and positive market sentiment, the company stands out in its ability to provide consistent payouts to its investors and maintain upward momentum in its stock performance.

While Great-West Lifeco scores slightly lower in value, growth, and resilience, its overall outlook remains promising. The company’s focus on serving the financial security needs of individuals in Canada and the United States positions it well for long-term success in the ever-evolving financial services industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Suncor Energy (SU) Earnings Surpass Expectations with Strong 2Q Adjusted Operating EPS

By | Earnings Alerts





Suncor 2Q Highlights

  • Adjusted operating EPS: C$1.27 (Estimate: C$1.09)
  • Earnings per share (EPS): C$1.22
  • Adjusted funds from operations (AFFO): C$3.40 billion
  • Cash flow from operations: C$3.83 billion (Estimate: C$3.12 billion)
  • Upstream production: 770,600 barrels per day
  • Refinery throughput: 430,500 barrels per day (Estimate: 397,576 barrels per day)
  • Refinery utilization: 92% (Estimate: 83.8%)
  • Analyst ratings: 10 buys, 12 holds, 0 sells



A look at Suncor Energy Smart Scores

FactorScoreMagnitude
Value4
Dividend4
Growth5
Resilience2
Momentum4
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Suncor Energy is well-positioned for long-term success with solid ratings across key factors. With a high Growth score of 5, the company is expected to expand and improve its performance over time. Additionally, Suncor Energy received strong scores in Value and Dividend, indicating good potential for returns and consistent payouts to investors. These factors suggest a positive outlook for the company’s financial health and shareholder returns.

However, Suncor Energy did receive a lower score in Resilience, which may indicate some vulnerability to economic challenges or industry fluctuations. Despite this, the company’s overall momentum score of 4 shows positive market sentiment and potential for growth. In summary, Suncor Energy, Inc. is a well-established integrated energy company with a focus on the Athabasca oil sands basin, positioning it for growth and profitability in the long term based on its Smartkarma Smart Scores.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

American Financial Group (AFG) Earnings: 2Q Core Operating EPS Surpasses Estimates at $2.56

By | Earnings Alerts
  • American Financial’s core operating EPS for Q2 2024 is $2.56, surpassing the estimate of $2.46.
  • This EPS shows an increase from last year’s $2.38.
  • The book value per share stands at $52.25, exceeding both last year’s value of $47.06 and the estimate of $51.48.
  • Adjusted book value per share has also increased to $56.19 from last year’s $52.90, beating the projected $54.75.
  • Core operating profit for the quarter is $58 million, marking a 3.6% year-over-year increase.
  • Analyst ratings include 2 buy recommendations and 6 hold recommendations, with no sell recommendations.

American Financial Group on Smartkarma

Analysts on Smartkarma, such as Baptista Research, are bullish on American Financial Group. In their report titled “American Financial Group Inc. (AFG): Initiation of Coverage – Strong Market Position in Specialty Insurance & Other Major Drivers,” the analysts highlighted the company’s solid performance in the first quarter of 2024. American Financial Group demonstrated an operating return on equity of 20%, with net written premiums increasing by 8% year-over-year. Co-CEOs Carl and Craig Lindner attributed this success to the company’s specialty insurance operations and effective investment strategies.

The report also noted that American Financial Group reported core net operating earnings of $2.76 per share during the quarter. While this figure represented a decrease from the previous year, it was mainly due to a reduced return on the company’s alternative investment portfolio compared to its exceptional performance in the prior year. Analysts see the company’s disciplined operating philosophy and strategic management of its investment portfolio as key drivers of its ongoing success in the competitive market.


A look at American Financial Group Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth3
Resilience3
Momentum3
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores for American Financial Group, the company has a moderate outlook across various key factors. With balanced scores of 3 out of 5 for Value, Dividend, Growth, Resilience, and Momentum, American Financial Group seems to be positioned in a stable manner for the long term. This indicates a steady performance across different aspects of the business, reflecting a solid foundation in its operations.

American Financial Group, Inc. focuses on providing multi-line property and casualty insurance alongside tax-deferred annuities and life and supplemental health insurance products in the United States. With consistent scores across different metrics, the company appears to maintain a reliable and resilient position in the financial market, suggesting a steady course for its future prospects.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Devon Energy (DVN) Earnings: Q2 Core EPS Beats Estimates with Strong Production and Cash Flow Growth

By | Earnings Alerts
  • Devon Energy‘s core earnings per share (EPS) for the second quarter were $1.41, outperforming the previous year’s $1.18 EPS and the estimated $1.28 EPS.
  • The company’s production for the second quarter was 707,000 barrels of oil equivalent per day (mboed), up from 662,000 mboed year-over-year and above the estimated 681,541 mboed.
  • Free cash flow for the second quarter stood at $587 million, marking an 80% increase year-over-year.
  • For the third quarter, Devon forecasts production between 670,000 and 690,000 mboed, compared to the estimated 677,956 mboed.
  • The company expects a marketing and midstream operating loss ranging from $5 million to $15 million in the third quarter.
  • Exploration expenses for the third quarter are anticipated to be between $0 to $5 million, against the estimate of $5.75 million.
  • Projected capital expenditure for the third quarter is $900 million, compared to the estimate of $810.4 million.
  • Devon revised its full-year production forecast to 677,000 to 688,000 mboed, up from the previous forecast of 655,000 to 675,000 mboed, but slightly lower than the estimate of 689,892 mboed.
  • Full-year marketing and midstream operating losses are expected to be $50 million, consistent with prior estimates of a $40 million to $50 million loss.
  • Full-year exploration expenses are projected between $15 million to $25 million, in line with the estimate of $25.6 million.
  • Full-year capital expenditure is forecasted to be between $3.3 billion to $3.6 billion, close to the estimate of $3.57 billion.
  • In the third quarter, Devon expects capital spending to be around $900 million and oil production to average between 319,000 to 325,000 barrels per day.
  • The company has increased its full-year 2024 production guidance by 5% based on strong first-half performance.
  • Devon repurchased 5.2 million shares of common stock at a total cost of $256 million in the second quarter.
  • A fixed-plus-variable dividend payout of $0.44 per share has been declared based on second-quarter results.
  • Analyst recommendations include 21 buys, 11 holds, and 0 sells for Devon Energy.

Devon Energy on Smartkarma

Analyst coverage of Devon Energy on Smartkarma reveals positive sentiment towards the company’s recent performance and future prospects. Baptista Research, in their report “Devon Energy Corporation: Leveraging Technology and Methodologies to Improve Extraction Efficiency! – Major Drivers,” highlights how Devon Energy exceeded operational and financial targets in Q1 2024. The company demonstrated strong production output, driven by factors such as improved well productivity and infrastructure optimization in the Delaware Basin.

In another report by Baptista Research titled “Devon Energy: Enhancements In Bakken & Eagle Ford Resources & 5 Other Growth Drivers,” the focus is on Devon Energy‘s fourth-quarter earnings, which showed promising signs for future growth. The report emphasizes the company’s achievements in 2023, positive projections for 2024, valuable resources in their portfolio, and strategic allocation of free cash flow. Baptista Research‘s evaluation aims to provide insights into potential influences on Devon Energy‘s stock price and conducts an independent valuation using a Discounted Cash Flow (DCF) methodology.


A look at Devon Energy Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth5
Resilience3
Momentum3
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Devon Energy Corporation, an independent energy company with a primary focus on oil and gas exploration, production, and transportation, has received varying Smart Scores across different factors. The company scores well in areas such as Dividend and Growth, indicating a positive outlook for investors seeking stable returns and potential growth opportunities. This suggests that Devon Energy may be a favorable choice for those interested in companies with strong dividend policies and potential for expansion.

While the company scores moderately in Value, Resilience, and Momentum, it indicates that Devon Energy may have some room for improvement in these areas to enhance its overall performance. Investors looking for companies with good value propositions and strong momentum trends might find Devon Energy slightly below top-performing companies in these aspects. However, with a strong emphasis on growth and dividends, Devon Energy presents itself as a promising long-term investment option in the energy sector.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Intl Flavors & Fragrances (IFF) Earnings: 2Q Net Sales Exceed Estimates at $2.89 Billion

By | Earnings Alerts
  • International Flavors’ net sales for Q2 2024 were $2.89 billion, slightly down by 1.4% year-over-year, but above the estimated $2.83 billion.
  • The Nourish segment reported net sales of $1.48 billion, a decrease of 5.5% year-over-year, meeting the estimate of $1.48 billion.
  • Health & Biosciences segment saw net sales increase by 6.9% year-over-year to $558 million, surpassing the estimate of $533.6 million.
  • Scent segment achieved net sales of $603 million, up by 1.9% year-over-year, beating the estimate of $585.7 million.
  • Pharma Solutions segment reported net sales of $250 million, a slight decline of 0.4% year-over-year, but exceeding the estimate of $231.1 million.
  • Adjusted EPS excluding amortization was $1.16, up from 86 cents year-over-year, surpassing the estimate of 97 cents.
  • Adjusted operating EBITDA came in at $588 million, a 15% increase year-over-year, above the estimate of $531.1 million.
  • Analyst ratings include 11 buys, 11 holds, and 1 sell.

Intl Flavors & Fragrances on Smartkarma

Analysts at Baptista Research on Smartkarma have provided two insightful reports on International Flavors & Fragrances (IFF). In their report titled “International Flavors & Fragrances (IFF): These Are The 7 Pivotal Factors Catalyzing Its Growth! – Financial Forecasts,” the analysts noted a mixed performance in the company’s first quarter of 2024. They highlighted achievements such as volume growth for the first time since early 2022 and a double-digit increase in comparable adjusted EBITDA, attributing these gains to contributions from various segments.

Another report by Baptista Research, “International Flavors & Fragrances (IFF): New Launches,” focused on the company’s fourth quarter and full-year 2023 earnings. The report highlighted a 1% increase in comparable currency-neutral sales and a 17% growth in comparable currency-neutral EBITDA for the fourth quarter, showing resilience within the company’s operational framework despite a reported sales decline. These reports provide valuable insights for investors following IFF’s performance.


A look at Intl Flavors & Fragrances Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth2
Resilience2
Momentum5
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

International Flavors & Fragrances Inc. is positioned well for the long term, according to Smartkarma Smart Scores. This reflects a positive outlook on the company’s momentum, indicating strong potential for growth in the future. While the scores for growth and resilience are moderate, the high momentum score suggests a promising trajectory for the company in the coming years.

Having a balanced mix of value and dividend scores, Intl Flavors & Fragrances is showing stability in its financial performance. With a focus on creating and supplying flavors and fragrances for various industries, the company’s diverse portfolio enhances its resilience. Overall, the Smart Scores point towards a favorable long-term outlook for Intl Flavors & Fragrances, supported by its established position in the food, beverage, personal care, and household products markets.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Amgen Inc (AMGN) Earnings: 2Q Adjusted EPS Falls Short of Estimates Despite Revenue Growth

By | Earnings Alerts
  • Amgen’s adjusted EPS for Q2 was $4.97, missing the estimate of $4.98 and down from $5 year-over-year (y/y).
  • Revenue for Q2 reached $8.39 billion, a 20% increase y/y, surpassing the estimate of $8.34 billion.
  • Product sales were $8.04 billion, also a 20% increase y/y, slightly above the estimate of $8.03 billion.
  • Repatha’s revenue grew by 25% y/y to $532 million, just below the estimate of $533 million.
  • Prolia’s revenue was $1.17 billion, increasing 13% y/y and exceeding the estimate of $1.11 billion.
  • Evenity saw a 39% y/y revenue growth to $391 million, above the estimate of $367.1 million.
  • Blincyto revenue increased by 28% y/y to $264 million, surpassing the $252.3 million estimate.
  • Vectibix revenue was $270 million, an 8.9% increase y/y, beating the estimate of $257.9 million.
  • Kyprolis revenue grew 9% y/y to $377 million, slightly above the $374.6 million estimate.
  • Lumakras revenue reached $85 million, up 10% y/y, close to the estimate of $84.9 million.
  • Xgeva had a 6% y/y revenue increase to $562 million, surpassing the estimate of $548.3 million.
  • Nplate’s revenue was $346 million, up 12% y/y, compared to the estimate of $319.6 million.
  • Mvasi revenue decreased 20% y/y to $157 million, missing the $188 million estimate.
  • Tezspire’s revenue soared 76% y/y to $234 million, exceeding the $214.6 million estimate.
  • Otezla’s revenue dropped 9.3% y/y to $544 million, below the estimate of $578.8 million.
  • Enbrel revenue was $909 million, down 15% y/y and below the estimate of $970.4 million.
  • Amgevita revenue decreased 11% y/y to $133 million, falling short of the estimate of $180.5 million.
  • Tepezza net sales were $479 million, close to the $480.8 million estimate.
  • Krystexxa net sales reached $294 million, above the $281.7 million estimate.
  • Uplizna net sales were $92 million, above the estimate of $89.7 million.
  • Tavenos revenue was $71 million, up from $30 million y/y, outperforming the $58.8 million estimate.
  • Epogen revenue dropped 48% y/y to $32 million, missing the estimate of $43.7 million.
  • Aranesp revenue fell 4.7% y/y to $348 million, close to the estimate of $344.3 million.
  • Parsabiv revenue increased 22% y/y to $106 million, beating the $88.2 million estimate.
  • Neulasta revenue declined 56% y/y to $105 million, below the estimate of $134.5 million.
  • Other products revenue totaled $346 million, higher than the $313.7 million estimate.
  • Other revenue reached $347 million, up 15% y/y, surpassing the $338 million estimate.
  • Adjusted operating expenses were $4.52 billion, a 30% increase y/y, aligning closely with the estimate of $4.53 billion.
  • Adjusted R&D expenses were $1.42 billion, up 30% y/y and near the $1.45 billion estimate.
  • Adjusted SG&A expenses were $1.69 billion, a 36% increase y/y, aligning with the $1.7 billion estimate.
  • Adjusted operating income was $3.87 billion, up 10% y/y, slightly above the estimate of $3.83 billion.
  • Adjusted operating margin stood at

Amgen Inc on Smartkarma

Amgen Inc. has attracted positive analyst coverage on Smartkarma from Baptista Research. In the report titled “Amgen Inc.: Will The Increased Spending on Research and Development (R&D) Pay Off? – Major Drivers,” Baptista Research highlights the company’s strong Q1 2024 performance, with a 22% YoY increase in total revenue. The growth was driven by robust product sales from brands like Repatha, TEZSPIRE, EVENITY, Prolia, and BLINCYTO. Additionally, Amgen’s pipeline progress is promising, with anticipated approval for tarlatamab to provide an innovative cancer solution for small-cell lung cancer patients.

In another report, “Amgen Inc: An Analysis Of The Pipeline Progress and Development! – Major Drivers,” Baptista Research underscores Amgen’s strategic moves, including the acquisition of Horizon Therapeutics, which has contributed to the company’s growth. The report emphasizes the record annual sales of 18 Amgen medicines, further fueling optimism. Baptista Research aims to evaluate the factors influencing Amgen’s future price and conducts an independent valuation using a Discounted Cash Flow methodology, indicating a bullish sentiment towards the company’s prospects.


A look at Amgen Inc Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth3
Resilience2
Momentum5
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Amgen Inc., the independent biotechnology medicines company, is showing a promising long-term outlook based on Smartkarma’s Smart Scores. With a strong momentum score of 5, Amgen Inc. exhibits significant positive market momentum, suggesting potential growth opportunities ahead. Additionally, the company scores well in both the Dividend and Growth categories, with scores of 3 for each, indicating a solid foundation for future growth and income generation. While the Value and Resilience scores are slightly lower at 2, the overall outlook for Amgen Inc. appears positive due to its robust performance in key areas.

Specializing in human therapeutics, Amgen Inc. is dedicated to developing innovative medicines for severe illnesses. By leveraging advancements in cellular and molecular biology, the company is at the forefront of creating groundbreaking treatments that address critical healthcare needs. As indicated by its Smart Scores, Amgen Inc.’s focus on value creation, growth potential, and market momentum positions it well for sustained success in the competitive biotechnology industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Trex Company (TREX) Earnings: 2Q Net Sales Miss Estimates Despite Strong EBITDA and EPS Growth

By | Earnings Alerts



Trex 2Q Performance Summary

  • Net sales for Trex in Q2 2024 totaled $376.5 million, a 5.6% increase year-over-year.
  • Sales figures fell short of the estimated $388 million.
  • EBITDA was reported at $130.4 million, up 11% from the previous year.
  • EBITDA surpassed the estimated $127.7 million.
  • Earnings per share (EPS) stood at 80 cents, compared to 71 cents year-over-year.
  • EBITDA margin was 34.6%, above the estimated 32.9%.
  • Analyst ratings include 10 buys, 9 holds, and 1 sell.



Trex Company on Smartkarma

Analyst coverage of Trex Company on Smartkarma by Baptista Research highlights the company’s strong performance in recent quarters. In their report titled “Trex Company: These 7 Pivotal Factors Are Driving Their Performance In 2024 & Beyond! – Financial Forecasts,” the analysts noted that Trex Company‘s first quarter 2024 earnings exceeded expectations, attributed to their leading position in the outdoor living category and increased demand for Trex-branded decking and railing products. The report also mentions a significant boost of approximately $75 million in sales due to strategic product restocking ahead of the season.

Furthermore, Baptista Research‘s analysis in “Trex Company Inc.: 7 Biggest Growth Drivers For The Company In 2024 & Beyond! – Financial Forecasts” reinforces the positive sentiment towards the company. Trex Company‘s solid performance in both quarterly and full year 2023 was highlighted, surpassing revenue guidance. The analysts credited this success to sustained channel growth and the introduction of new products expanding the company’s portfolio. These reports signify optimism in Trex Company‘s future prospects based on their recent achievements and strategic initiatives.


A look at Trex Company Smart Scores

FactorScoreMagnitude
Value2
Dividend1
Growth4
Resilience3
Momentum3
OVERALL SMART SCORE2.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts using the Smartkarma Smart Scores have forecast a positive long-term outlook for Trex Company, a manufacturer of non-wood decking alternative products. With a strong Growth score of 4, the company is expected to experience robust expansion in the foreseeable future. This growth potential is further supported by respectable Resilience and Momentum scores of 3 each, indicating the company’s ability to withstand market fluctuations and maintain a positive upward trajectory. Although the Value score is moderate at 2, the overall outlook for Trex Company appears optimistic based on these Smart Scores.

As per the Smartkarma analysis, Trex Company‘s Dividend score is low at 1, suggesting a lower focus on distributing dividends to shareholders. However, the company’s emphasis on growth and its ability to adapt to changing market dynamics seem to be key factors driving its overall positive outlook. With a global customer base, Trex Company‘s innovative decking and railing products, outdoor lighting, and accessory hardware offerings position it well for continued success in the industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Illumina Inc (ILMN) Earnings: 2Q Revenue Surpasses Estimates at $1.11 Billion

By | Earnings Alerts
  • Illumina reported second-quarter revenue of $1.11 billion, surpassing estimates of $1.09 billion.
  • Product revenue for the quarter was $927 million.
  • Service and other revenue amounted to $185 million.
  • The company achieved an adjusted gross margin of 69%, exceeding the estimated 66.1%.
  • Illumina’s cash and cash equivalents stood at $920 million, below the estimate of $1.32 billion.
  • Guidance for Core Illumina non-GAAP diluted EPS is set in the range of $3.80 to $3.95 for fiscal year 2024.
  • For fiscal year 2024, Core Illumina revenue guidance has been lowered to decline by 2% to 3% (1.5% to 2.5% in constant currency) compared to fiscal year 2023.
  • Non-GAAP operating margin guidance for Core Illumina has been raised to a range of 20.5% to 21% for fiscal year 2024.
  • CEO Jacob Thaysen highlighted the company’s disciplined execution on strategic priorities as a key driver of performance.
  • According to analyst ratings: 12 buys, 12 holds, and 3 sells.

Illumina Inc on Smartkarma

Analysts on Smartkarma, like Baptista Research, are closely monitoring Illumina Inc‘s market performance. In a report titled “Illumina Inc.: Will Its Market Dominance In Genetic Analysis Last? – Major Drivers,” they highlight the company’s strong first quarter of 2024. The quarter saw impressive results from high throughput consumables, increased revenue from partnerships, and successful NovaSeq X instruments deliveries. However, CEO Jacob Thaysen is cautious due to global economic uncertainties impacting customer purchasing decisions. Despite challenges posed by the pandemic, Illumina’s performance remains promising.

In another report by Baptista Research, “Illumina Inc: Will Its Market Dominance In Genetic Analysis Last In The Long Term? – Major Drivers,” analysts discuss the company’s successful 2023 but anticipate challenges in 2024 due to macroeconomic hurdles. Illumina exceeded expectations with around $1.12 billion in consolidated revenue in the fourth quarter of 2023, showing a 4% year-over-year growth. CEO Thaysen has highlighted the launch of NovaSeq X as a significant achievement for the company. As Illumina navigates market uncertainties, analysts are optimistic about its long-term prospects despite short-term challenges.


A look at Illumina Inc Smart Scores

FactorScoreMagnitude
Value3
Dividend1
Growth2
Resilience3
Momentum3
OVERALL SMART SCORE2.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Illumina Inc appears to have a mixed long-term outlook. With a moderate score in value, the company is perceived to offer fair investment value. However, its low score in dividends suggests that it may not be an attractive option for investors seeking regular income. In terms of growth and momentum, Illumina Inc received average scores, indicating a moderate potential for future growth and market performance. On the other hand, the company’s resilience score is relatively strong, highlighting its ability to withstand market challenges and maintain stability over time.

Illumina, Inc. is a leading developer, manufacturer, and marketer of integrated systems for genetic variation and biological function analysis. Its diverse range of products and services cater to the needs of genomic research centers, pharmaceutical firms, academic institutions, and biotechnology companies. Despite the varied Smartkarma Smart Scores, Illumina Inc‘s overall outlook suggests a company that holds promise for long-term investment, supported by its resilience and position in the genetic analysis market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars